Mr. Bhavesh Vikrambhai Bhavsar
Executive Director
Mr. Bhavesh Vikrambhai Bhavsar, is a pharmaceutical professional with technical background who has worked with Organisations such as Torrent Pharma, SPARC (Sun Pharma Advanced Research Centre), Astron Research Centre (Intas Pharma) and Emcure pharmaceuticals Ltd. He is specialized in the areas of Research &Development, Formulation Development, Quality, Compliance and Regulatory Affairs both for formulation development and finished dosage form manufacturing. In a career span of 17 years he has provided leadership to the above organizations rise to become global leaders in their specialized segments.
Mr. Bhavesh has successfully handled USFDA and other international regulatory inspections with good leadership and sound technical knowledge.
In the past 8 years, he has worked as senior position at Astron Research Centre (Intas Pharma) and Emcure pharmaceuticals. In these years, Research and Development at these organizations have been expanded exponentially. Apart from R&D expansions and capacity enhancements, he has given the organizations very sound Quality systems. As team player in each organization he is capable of filing innovative ANDA products all these years through efficient Regulatory pathway.
His strength/ expertise involves selecting good teams, grooming them and meeting organizational expectations all these years.
Mr. Bhavesh Bhavsar has joined KriGen Pharmaceuticals in the capacity of Whole-time Director designated as Executive Director responsible for the entire R&D Operations.
KriGen now has a leader to take the organization to the next level.
Mr. Hemal Naranbhai Patel
CFO / Director
Mr. Hemal Naranbhai Patel, is a B. Pharm and Master of Science (USA). He is a pharmaceutical professional with technical background who has worked with Organisations such as Maan Pharma and Sunshine Drugs (USA). Presently Mr. Hemal has associated and lead as a Chief Executive Officer of API bulk drug manufacturing companies i.e.RujaImpax Pvt. Ltd since 2012, Maharshi Pharma Chem Pvt. Ltd since 2014, Brichem Science Pvt Ltd since 2016 and ApisterLifescience Pvt. Ltd since 2017.He is specialized in the areas of API formulation/ manufacturing, Strategic Planning, Day-to-Day Operations, Financial Management and Legal Responsibility.
In a career span of 16 years he has provided leadership to the above organizations rise to become global leaders in their specialized segments.
Mr. Hemal Patel successfully handled FDA and other inspections with good leadership and sound technical knowledge.
In the past 6 years, he has worked as senior position atabove mentioned API bulk drug manufacturing companies. In these years, API manufacturing at these organizations have been expanded exponentially. Apart from API manufacturing expansions and capacity enhancements, he has given the organizations very sound Quality systems. As team player in each organization he is capable of filing innovative products all these years through efficient regulatory pathway.
His strength/ expertise involves selecting good teams, grooming them and meeting organizational expectations all these years.
Mr. Hemal Patel has joined KriGen Pharmaceuticals in the capacity of Whole-time Director designated as CFO Director responsible for the entire R&D Operations.
KriGen now has a leader to take the organization to the next level.
Dr, Rajesh Gami
Director
The academic credentials of Dr. Rajesh Gami include a Pharm.D. and an M.S. in Biotechnology (UK). He has a strong technical background and is a specialist in the field of pharmaceuticals. For the past 16 years, he has led a wide variety of companies to the forefront of their industries on a global scale. Dr. Gami co-founded the pharmaceutical businesses Apister Life Sciences Pvt Ltd, Brichem Sciences Pvt Ltd India, and Womanora INC, where he has worked as quality and administrative director since 2016. Every one of these businesses is devoted to the novel research, production, and distribution of APIs for the pharmaceutical industry, with a focus on the Hormones, Steroids, and Fermenter product lines, all of which are destined for export to the Asian and East African markets. Growth in both research and APIs production at these institutions may be directly attributed to Dr. Gami's competent leadership. Besides that, he has given the companies efficient Quality systems. As a responsible member of the team, he is able to file novel products in a timely manner and follow the appropriate regulatory procedures. His areas of competence include team selection, development, and the achievement of organizational goals.
Dr. Gami's responsibilities at KriGen Pharmaceuticals include all aspects of the company's activities, including but not limited to, research and development, manufacturing, strategic planning, day-to-day operations, and legal oversight.
KriGen has a new leader who will help it reach new heights.
